Type segmentation differentiates interactive devices by the primary biomaterial and its mechanism of action. Foam interactive dressings, leveraging hydrophilic polyurethane matrices that swell on exudate uptake while maintaining a moist interface, constitute the largest sub-category—about 34 % of 2023 dollar sales—because they pair absorption with low-adherence release profiles, suiting moderate-to-heavy exuding ulcers. Hydrocolloid interactive dressings, forming a cohesive gel upon contact with wound fluid, rank second (26 %) and are preferred for low-exuding diabetic and pressure ulcers owing to their bacterial barrier and autolytic debridement properties; however, their occlusive nature limits use in infected sites. Alginate interactive variants, derived from calcium-sodium alginate fibres, command roughly 18 % of revenues, delivering hemostasis and high wet-strength removal in venous leg ulcers. Hydrogel interactive sheets (12 %) and interactive antimicrobial-impregnated mesh dressings (10 %) complete the market taxonomy, with the latter posting double-digit growth as hospital stewardship programs target biofilm-related recalcitrant wounds. This market taxonomy clarifies how material science translates into addressable market size and pricing tiers across the chronic-care continuum.